Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal [enclomifene] to a Topical Testosterone [Testim] in Men Previously Treated With Topical Testosterone.

X
Trial Profile

A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal [enclomifene] to a Topical Testosterone [Testim] in Men Previously Treated With Topical Testosterone.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Enclomifene (Primary) ; Testosterone
  • Indications Hypogonadism; Male infertility
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Repros Therapeutics
  • Most Recent Events

    • 10 Apr 2013 Results assessing the effects of treatment on levels of IGF-1 and hormones presented at the 104th Annual Meeting of the American Association for Cancer Research.
    • 10 Nov 2010 In preparation for phase 3 trials, the FDA opined that this phase 2B study would provide for a more solid database for design and eventual approval of such studies under an SPA, according to a Repros Therapeutics media release.
    • 14 Aug 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top